Outcomes after biochemical or clinical progression in patients with multiple myelomaSarah Goldman‐Mazur, Shaji Kumar, Martha Q. Lacy et al.|Blood Advances|2022Cited by 28
Second- and third-line treatment strategies in multiple myeloma: a referral-center experienceSarah Goldman‐Mazur, Shaji Kumar, Alissa Visram et al.|Blood Cancer Journal|2022Cited by 13